Market Signals Review: Eli Lilly and Company: Two Market-Implied Ratings Slip from Recent Highs, but Stay Strong - Moody's Capital Markets Research

Market Signals Review: Eli Lilly and Company: Two Market-Implied Ratings Slip from Recent Highs, but Stay Strong

Market Signals Review: Eli Lilly and Company: Two Market-Implied Ratings Slip from Recent Highs, but Stay Strong - Moody's Capital Markets Research
Market Signals Review: Eli Lilly and Company: Two Market-Implied Ratings Slip from Recent Highs, but Stay Strong
Published Dec 01, 2014
8 pages — Published Dec 01, 2014
Price US$ 200.00  |  Buy this Report Now

About This Report

  
Abstract:

CORPORATESISSUER COMMENT 01 DECEMBER 2014ELI LILLY AND COMPANY (LLY)Moody s Senior Unsecured Rating A2Moodys Outlook STABond-Implied Rating A1CDS-Implied Rating Aa2EDF-Implied Rating AaaAs of 11/28/2014ANALYST CONTACTSAllerton G. Smith 212-553-4058 Sr Dir-Sr Research Analyst allerton.smith@moodys.comABOUT CAPITAL MARKETS RESEARCHAnalyses from Moodys Capital Markets Research, Inc. (CMR) focus on explaining signals from the credit and equity markets. The publications address whether market signals, in the opinion of the groups analysts, accurately reflect the risks and investment opportunities associated with issuers and sectors. CMR research thus complements the fundamentally-oriented research offered by Moodys Investors Service (MIS), the rating agency.CMR is part of Moodys Analytics, which is one of the two operating businesses of Moodys Corporation. Moodys Analytics (including CMR) is legally and organizationally separated from Moodys Investors Service and operates on an arms length basis from the ratings business. CMR does not provide investment advisory services or products.View the CMR FAQ Contact the CMR team Follow us on TwitterMoodys Analytics markets and distributes all Moodys Capital Markets Research, Inc. materials. Moodys Capital Markets Research, Inc. is a subsidiary of Moodys Corporation. Moodys Analytics does not provide investment advisory services or products. For further detail, please see the last page.Market Signals ReviewEli Lilly and Company: Two Market-Implied Ratings Slip from Recent Highs, but Stay Strong The CDS- and bond-implied ratings for Eli Lilly both dipped by a notch from their highest levels over the last 90 days. Nevertheless, they remain strong and show positive implied-ratings gaps.Eli Lilly announced third-quarter results (including a 16% drop in revenues) on October 23, with profits slightly missing the Wall Street consensus estimates (non-GAAP EPS was $0.66 vs. consensus $0.67) following patent expirations for Cymbalta and Evista.FIGURE 1. ELI LILLY: MOODYS AND MARKET-IMPLIED RATINGS, LAST 90 DAYS (DAILY DATA)MOODY'S ANALYTICS CORPORATES2 01 DECEMBER 2014 MARKET SIGNALS REVIEW ELI LILLY AND COMPANY: TWO MARKET-IMPLIED RATINGS SLIP FROM RECENT HIGHS, BUT STAY STRONGThe CDS-implied rating was Aa2 on September 1, and rose to Aa1 on several occasions over the last 90 days (Figure 1). However, these gains were not sustainable and the CDS-implied rating slipped down from Aa1 on November 10 to Aa2 once again.The bond-implied rating moved between A3 and Aa3 over the last 90 days. On October 15 it was Aa3 (equaling its recent apex), but has retreated to A1 at present. On September 2 the bond-implied rating rose by one notch, from A2 to A1.The EDF'-implied rating has been unchanged at Aaa over the last three months.According to our ratings gap-conditioned transition matrices, companies rated A2 with a bond-implied rating of A1 outperformed the broad market 30% of the ...

  
Source:
Document ID
PBC_1001725
Report Type
Market Signals Review
Format:
PDF Adobe Acrobat
Buy Now

Moody's Capital Markets Research—Moody's Analytics offers research, unique tools and best practices for measuring and managing risk through expertise and experience in credit analysis, economic research and financial risk management.

About the Author


Cite this Report

  
MLA:
Moody's Capital Markets Research. "Market Signals Review: Eli Lilly and Company: Two Market-Implied Ratings Slip from Recent Highs, but Stay Strong" Dec 01, 2014. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Moody-s-Capital-Markets-Research/Market-Signals-Review-Eli-Lilly-and-Company-Two-Market-Implied-Ratings-Slip-from-Recent-Highs-but-Stay-Strong-2141-2392>
  
APA:
Moody's Capital Markets Research. (2014). Market Signals Review: Eli Lilly and Company: Two Market-Implied Ratings Slip from Recent Highs, but Stay Strong Dec 01, 2014. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Moody-s-Capital-Markets-Research/Market-Signals-Review-Eli-Lilly-and-Company-Two-Market-Implied-Ratings-Slip-from-Recent-Highs-but-Stay-Strong-2141-2392>
  
US$ 200.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.